Former Chief Commercial Officer · RHYTHM PHARMACEUTICALS, INC. (RYTM)

Nithya Desikan

A named executive officer of RHYTHM PHARMACEUTICALS in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,943,971

Salary $305,510Stock awards $105,000

FY2019: $1,810,241

5th of 6 named executive officers at Rhythm Pharmaceuticals by FY2020 total.

6 named officers on file for RHYTHM PHARMACEUTICALS, FY2020

Nithya Desikan’s pay file — $29

  • 2 fiscal years of pay, line by line
  • RYTM’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how RHYTHM PHARMACEUTICALS’s whole pay program stands against its peers

  • RHYTHM PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RYTM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2021 (DEF 14A).

Free

Get Nithya Desikan’s full pay file as a PDF — free

More than this page: up to 10 years of Nithya’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Nithya Desikan compensation by year

RHYTHM PHARMACEUTICALS Summary Compensation Table · all 2 fiscal years held
In US dollars, as RHYTHM PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$379,063$305,510
Bonus$0$0
Stock awards$0$105,000
Option awards$1,286,061$1,533,841
Non-equity incentive$145,117$0
Pension and deferred compensation$0$0
All other$0$104,620
Total$1,810,241$1,943,971

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RHYTHM PHARMACEUTICALS, INC. DEF 14A filed April 27, 2021, accession 0001104659-21-055591, and prior-year filings. Open the filing on EDGAR.

How this page was built: the RHYTHM PHARMACEUTICALS, INC. filed document, accession 0001104659-21-055591. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2021.

$1.8M
$1.9M
FY19
FY20
SalaryNon-equity incentiveStock awardsOption awardsAll other

RHYTHM PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
David MeekerChief Executive Officer$14,277,367
Keith GottesdienerFormer President and Chief Executive Officer$3,449,169
Hunter SmithChief Financial Officer$2,662,468
Murray StewartFormer Chief Medical Officer$2,300,314
Nithya Desikan · this pageFormer Chief Commercial Officer$1,943,971
Jennifer ChienExecutive Vice President, Head of North America$1,819,617

The full RHYTHM PHARMACEUTICALS compensation record

free company brief

This page is one person within RHYTHM PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the RHYTHM PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RHYTHM PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Nithya Desikan's compensation dossier · One-time report. No refunds.